News Snapshot:
Joinn Labs launches $844m Hong Kong IPO By Jonathan Breen 06.00 AM Mainland China-listed Joinn Laboratories has kicked off bookbuilding for its up to HK$6.54bn ($843.9m) Hong Kong IPO, becoming one of the first companies to hit the equities market following the Chinese New Year break. The issuer, a non-clinical contract research organisation (CRO) that assesses drug safety, has begun marketing its trade after two weeks of pre-deal investor education leading up to the Chinese New Year holidays. Markets in Hong Kong were closed from February 12 until Monday, February 15. Joinn and the ...
